PNC Financial Services Group’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,620
Closed -$1.46K 4962
2024
Q2
$1.46K Hold
1,620
﹤0.01% 4340
2024
Q1
$2.4K Sell
1,620
-2,168
-57% -$2.35K ﹤0.01% 4158
2023
Q4
$4.36K Hold
3,788
﹤0.01% 3981
2023
Q3
$8.11K Buy
3,788
+1
+0% +$2 ﹤0.01% 3841
2023
Q2
$14.5K Hold
3,787
﹤0.01% 3702
2023
Q1
$10.6K Hold
3,787
﹤0.01% 3797
2022
Q4
$10.2K Buy
3,787
+1,620
+75% +$8.95K ﹤0.01% 3773
2022
Q3
$10K Hold
2,167
﹤0.01% 3788
2022
Q2
$24K Hold
2,167
﹤0.01% 3419
2022
Q1
$30K Hold
2,167
﹤0.01% 3382
2021
Q4
$52K Buy
+2,167
New +$51.1K ﹤0.01% 3096

Other funds holding BTCY

PNC Financial Services Group's BTCY Position: Q3 2024 in Review

PNC Financial Services Group sold out of Biotricity, Inc. Common Stock (BTCY) in Q3 2024, closing a stake of 1,620 shares — an estimated $1.46K sold.

PNC Financial Services Group first reported a position in BTCY in Q4 2021 and held it in 11 quarters. The position peaked at $52K in Q4 2021. 5 funds tracked by Wall St. Rank hold BTCY as of Q3 2024.

  • PNC Financial Services Group reported no remaining Biotricity, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • PNC Financial Services Group sold 1,620 Biotricity, Inc. Common Stock shares in Q3 2024, an estimated $1.46K.
  • PNC Financial Services Group first reported a position in Biotricity, Inc. Common Stock in Q4 2021 and held it in 11 quarters.
  • PNC Financial Services Group's Biotricity, Inc. Common Stock position peaked at $52K in Q4 2021.
  • 5 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q3 2024.

Based on PNC Financial Services Group's 13F filing for Q3 2024, filed 8 Nov 2024.